ClinicalTrials.Veeva

Menu
V

Vista Health Research | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Risankizumab
Ozanimod
Guselkumab
Filgotinib
LYT-100
Iron
Permethrin
Elagolix
Estradiol
MOR106

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 32 total trials

A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR)

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Guselkumab
Drug: Placebo

The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in...

Active, not recruiting
Colitis, Ulcerative
Drug: Guselkumab Dose 2
Other: Placebo

The goal of the Phase 3a part of this clinical trial is to determine the optimal dose that will be used in the Phase 3b part of this clinical trial....

Enrolling
Primary Membranous Nephropathy
Drug: SNP-ACTH (1-39) Gel
Drug: Rituximab

Trial sponsors

AbbVie logo
G
Janssen (J&J Innovative Medicine) logo
Celgene logo
L
Sanofi logo
X
Allergan logo
American Regent logo
Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems